ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Clinical trial NCT00396240 · WITHDRAWN

Trial details

NCT number: NCT00396240
Sponsor: AstraZeneca
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Hypercholesterolaemia

Start date: 2002-02-01
Enrollment: 1294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.